Quick Answer
MAXCYTE, INC. reported Total Revenue of $33.03 million for fiscal year 2025.
MAXCYTE, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $33.03M | -14.5% |
| 2024 | $38.63M | -6.4% |
| 2023 | $41.29M | -6.7% |
| 2022 | $44.26M | +30.6% |
| 2021 | $33.89M | +29.5% |
| 2020 | $26.17M | +21.0% |
| 2019 | $21.62M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.83M | -16.4% | -19.7% |
| June 30, 2025 | $8.51M | -18.4% | -18.1% |
| March 31, 2025 | $10.39M | -8.4% | +27.3% |
| September 30, 2024 | $8.16M | +2.0% | -21.7% |
| June 30, 2024 | $10.43M | +15.3% | -8.0% |
| March 31, 2024 | $11.34M | +32.3% | +41.7% |
| September 30, 2023 | $8.00M | -24.8% | -11.5% |
| June 30, 2023 | $9.04M | -5.9% | +5.4% |
- MAXCYTE, INC. showed a decrease of -14.5% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2025 period, MAXCYTE, INC.’s total revenue has grown by 52.8% (from $21.62 million to $33.03 million).
- The most recent figure is from MAXCYTE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: